![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-desktop-header-01gif-33629.gif)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-mob-header-01gif-17728.gif)
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
0
EU WC
0
Listed Suppliers
0
USA (Orange Book)
0
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
0
Annual Reports
0
0
69
PharmaCompass offers a list of Fusidic Acid API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Fusidic Acid manufacturer or Fusidic Acid supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Fusidic Acid manufacturer or Fusidic Acid supplier.
PharmaCompass also assists you with knowing the Fusidic Acid API Price utilized in the formulation of products. Fusidic Acid API Price is not always fixed or binding as the Fusidic Acid Price is obtained through a variety of data sources. The Fusidic Acid Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Diethanolamine fusidate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Diethanolamine fusidate, including repackagers and relabelers. The FDA regulates Diethanolamine fusidate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Diethanolamine fusidate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Diethanolamine fusidate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Diethanolamine fusidate supplier is an individual or a company that provides Diethanolamine fusidate active pharmaceutical ingredient (API) or Diethanolamine fusidate finished formulations upon request. The Diethanolamine fusidate suppliers may include Diethanolamine fusidate API manufacturers, exporters, distributors and traders.
click here to find a list of Diethanolamine fusidate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Diethanolamine fusidate DMF (Drug Master File) is a document detailing the whole manufacturing process of Diethanolamine fusidate active pharmaceutical ingredient (API) in detail. Different forms of Diethanolamine fusidate DMFs exist exist since differing nations have different regulations, such as Diethanolamine fusidate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Diethanolamine fusidate DMF submitted to regulatory agencies in the US is known as a USDMF. Diethanolamine fusidate USDMF includes data on Diethanolamine fusidate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Diethanolamine fusidate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Diethanolamine fusidate suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Diethanolamine fusidate Drug Master File in Korea (Diethanolamine fusidate KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Diethanolamine fusidate. The MFDS reviews the Diethanolamine fusidate KDMF as part of the drug registration process and uses the information provided in the Diethanolamine fusidate KDMF to evaluate the safety and efficacy of the drug.
After submitting a Diethanolamine fusidate KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Diethanolamine fusidate API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Diethanolamine fusidate suppliers with KDMF on PharmaCompass.
A Diethanolamine fusidate CEP of the European Pharmacopoeia monograph is often referred to as a Diethanolamine fusidate Certificate of Suitability (COS). The purpose of a Diethanolamine fusidate CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Diethanolamine fusidate EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Diethanolamine fusidate to their clients by showing that a Diethanolamine fusidate CEP has been issued for it. The manufacturer submits a Diethanolamine fusidate CEP (COS) as part of the market authorization procedure, and it takes on the role of a Diethanolamine fusidate CEP holder for the record. Additionally, the data presented in the Diethanolamine fusidate CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Diethanolamine fusidate DMF.
A Diethanolamine fusidate CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Diethanolamine fusidate CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Diethanolamine fusidate suppliers with CEP (COS) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Diethanolamine fusidate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Diethanolamine fusidate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Diethanolamine fusidate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Diethanolamine fusidate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Diethanolamine fusidate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Diethanolamine fusidate suppliers with NDC on PharmaCompass.
Diethanolamine fusidate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Diethanolamine fusidate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Diethanolamine fusidate GMP manufacturer or Diethanolamine fusidate GMP API supplier for your needs.
A Diethanolamine fusidate CoA (Certificate of Analysis) is a formal document that attests to Diethanolamine fusidate's compliance with Diethanolamine fusidate specifications and serves as a tool for batch-level quality control.
Diethanolamine fusidate CoA mostly includes findings from lab analyses of a specific batch. For each Diethanolamine fusidate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Diethanolamine fusidate may be tested according to a variety of international standards, such as European Pharmacopoeia (Diethanolamine fusidate EP), Diethanolamine fusidate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Diethanolamine fusidate USP).